Skip to main content

Henry Schein, Inc. (HSIC) Stock Analysis

Range Bound setup

SellVALUE-TRAP 1/5Moderate Confidence

Healthcare · Medical Distribution

Sell if holding. At $72.90, A.R:R 0.6:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 4.0%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.0).

Henry Schein distributes healthcare products and services to dental and medical practitioners globally through Global Distribution/Value-Added Services, Global Specialty Products (implants, endodontics, orthopedics), and Global Technology (practice management software) segments,... Read more

$72.90+4.0% A.UpsideScore 4.9/10#4 of 5 Medical Distribution
QualityF-score8 / 9FCF yield3.50%
Stop $67.88Target $75.88(analyst − 13%)A.R:R 0.6:1
Analyst target$87.21+19.6%14 analysts
$75.88our TP
$72.90price
$87.21mean
$64
$100

Sell if holding. At $72.90, A.R:R 0.6:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 4.0%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.0). Chart setup: RSI 41 mid-range, Bollinger mid-band. Score 4.9/10, moderate confidence.

Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 78d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

Recent Developments — Henry Schein, Inc.

Generated 2026-05-20T21:06:21Z.

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Risks
Thin upside margin: 4.0%
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.0)
Consecutive earnings misses (2)

Key Metrics

P/E (TTM)22.0
P/E (Fwd)12.3
Mkt Cap$8.3B
EV/EBITDA12.8
Profit Mgn3.0%
ROE8.8%
Rev Growth6.3%
Beta0.82
DividendNone
Rating analysts24

Quality Signals

Piotroski F8/9

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
2.9
Revenue Growth
4.1

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Surprise Avg
0.0
Earnings History
3.3
Earnings Timing
5.0
Erm
6.0
Earnings concerns: 2B/2M
GatesA.R:R 0.6 < 1.5@spotMomentum 4.6<5.5 (soft — BUY_NOW allowed but watch)Momentum 4.6>=4.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 78d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Moderate
RSI
41 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $68.70Resistance $81.10

Price Targets

$68
$76
A.Upside+4.1%
A.R:R0.6:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Reward/Risk 0.6:1 at current price — below 1.5:1 minimum

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-08-04 (78d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is HSIC stock a buy right now?

Sell if holding. At $72.90, A.R:R 0.6:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 4.0%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.0). Chart setup: RSI 41 mid-range, Bollinger mid-band. Prior stop was $67.88. Score 4.9/10, moderate confidence.

What is the HSIC stock price target?

Take-profit target: $75.88 (+4.0% upside). Prior stop was $67.88. Stop-loss: $67.88.

What are the risks of investing in HSIC?

Thin upside margin: 4.0%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.0); Consecutive earnings misses (2).

Is HSIC overvalued or undervalued?

Henry Schein, Inc. trades at a P/E of 22.0 (forward 12.3). TrendMatrix value score: 6.4/10. Verdict: Sell.

What do analysts say about HSIC?

24 analysts cover HSIC with a consensus score of 3.8/5. Average price target: $87.

What does Henry Schein, Inc. do?Henry Schein distributes healthcare products and services to dental and medical practitioners globally through Global...

Henry Schein distributes healthcare products and services to dental and medical practitioners globally through Global Distribution/Value-Added Services, Global Specialty Products (implants, endodontics, orthopedics), and Global Technology (practice management software) segments, serving over one million customers worldwide. Top 10 suppliers in distribution accounted for ~25% of aggregate purchases; single largest supplier ~4%. No single customer represents a material concentration.

Related stocks: COR (Cencora, Inc.) · CAH (Cardinal Health, Inc.) · AHG (Akso Health Group) · AUPH (Aurinia Pharmaceuticals Inc) · NBIX (Neurocrine Biosciences, Inc.)